ANW vs BOT: Side-by-Side Comparison
Compare Immuron Limited (ANW) and Botanix Pharmaceuticals Ltd (BOT) side by side: market cap EUR 3.55M vs AUD 57.42M. Financials, growth and model signals on Bullrun.
| Metric | ANW | BOT |
|---|---|---|
| Company | Immuron Limited | Botanix Pharmaceuticals Ltd |
| Country / Exchange | Australia · F | Australia · AU |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | EUR 3.55M | AUD 57.42M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | EUR 7.29M | AUD 5.76M |
| Revenue growth YoY | +48.6% | +856.6% |
| Net income | EUR -5.22M | AUD -86.40M |
| Gross margin | 65.4% | 40.3% |
| Diluted EPS | -0.02 | -0.05 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.